Uniplan Investment Counsel’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Uniplan Investment Counsel's PFE Position: Q1 2020 in Review
Uniplan Investment Counsel sold out of Pfizer (PFE) in Q1 2020, closing a stake of 224,906 shares — an estimated $8.36M sold.
Uniplan Investment Counsel first reported a position in PFE in Q2 2015 and held it in 19 quarters. The position peaked at $27.9M in Q2 2015. 2,437 funds tracked by Wall St. Rank hold PFE as of Q1 2020.
- Uniplan Investment Counsel reported no remaining Pfizer position as of Q1 2020 after selling out during the quarter.
- Uniplan Investment Counsel sold 224,906 Pfizer shares in Q1 2020, an estimated $8.36M.
- Uniplan Investment Counsel first reported a position in Pfizer in Q2 2015 and held it in 19 quarters.
- Uniplan Investment Counsel's Pfizer position peaked at $27.9M in Q2 2015.
- 2,437 funds tracked by Wall St. Rank held Pfizer as of Q1 2020.
Based on Uniplan Investment Counsel's 13F filing for Q1 2020, filed 15 May 2020.